A patient in China with hepatocellular carcinoma survived 171 days following xenotransplantation with a genetically modified ...

PureHealth Research continues to expand its approach to full-body wellness with a portfolio of pure health products designed to support interconnected biological systems. Rather than targeting ...

The liver of a 56-year-old male patient was severely damaged. Suffering from chronic hepatitis B and heavy alcohol consumption, he developed severe liver failure. Without a transplant, survival was ...

Fatty liver disease is often discovered during routine health check-ups and is commonly linked to diet, weight gain, or ...

The British pharma giant will hand off its experimental itch treatment to Italian company Alfasigma as it focuses on broader ...

Researchers from The University of Osaka find that chronic liver congestion is linked to severe liver diseases through a specific signaling pathway in ...

News of black rain falling on Tehran felt all too familiar to Nejat Rahmanian as he scrolled through alerts on social media ...

Gut microbiota may shape liver metastasis in small cell lung cancer and influence treatment response. Read more.

GSK’s linerixibat is currently under regulatory review in the US, Europe, and China, amongst other regions.

GSK and Alfasigma have signed a licensing agreement granting Alfasigma worldwide exclusive rights to develop, manufacture and commercialise linerixibat, an investigational IBAT inhibitor for the ...

As we wrap up our series on childhood vaccinations and the recommendations to get them, we want to consider with you more ...

The Food and Drugs Authority has issued an urgent public warning after investigations revealed that a substance being sold as “Sukudai”, promoted as a “heart-cleansing” remedy, contains dangerous ...